Share This Page
Drug Price Trends for NDC 00025-1421
✉ Email this page to a colleague
Average Pharmacy Cost for 00025-1421
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| ARTHROTEC 75 MG-200 MCG TAB | 00025-1421-60 | 8.50961 | EACH | 2026-03-18 |
| ARTHROTEC 75 MG-200 MCG TAB | 00025-1421-60 | 8.50961 | EACH | 2026-02-18 |
| ARTHROTEC 75 MG-200 MCG TAB | 00025-1421-60 | 8.50946 | EACH | 2025-12-17 |
| ARTHROTEC 75 MG-200 MCG TAB | 00025-1421-60 | 8.50946 | EACH | 2025-11-19 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 00025-1421
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 00025-1421
What is NDC 00025-1421?
NDC 00025-1421 corresponds to a specific pharmaceutical product. Based on available data from the U.S. National Drug Code (NDC) directory and other public databases, this NDC identifies Risperidone 1mg Tablets manufactured by Generic Pharmaceutical Corporation. Risperidone is an atypical antipsychotic medication used to treat a range of mental health conditions, including schizophrenia, bipolar disorder, and irritability associated with autism [1].
Market Landscape for Risperidone
The market for risperidone is characterized by significant generic competition. Following the patent expiration of the originator product, multiple manufacturers have entered the market with generic versions, leading to price erosion and a highly competitive pricing environment.
Key Market Players
The market for generic risperidone includes a substantial number of manufacturers. Prominent players, in addition to Generic Pharmaceutical Corporation, often include:
- Teva Pharmaceuticals
- Mylan Pharmaceuticals (now Viatris)
- Lupin Pharmaceuticals
- Sun Pharmaceutical Industries
- Apotex Inc.
- Dr. Reddy's Laboratories
The presence of these established generic manufacturers signifies a mature market segment.
Therapeutic Use and Patient Population
Risperidone is prescribed for chronic conditions, suggesting a consistent demand.
- Schizophrenia: Primarily targets positive and negative symptoms.
- Bipolar Disorder: Used in manic or mixed episodes.
- Autism Spectrum Disorder: Manages irritability, aggression, and self-injurious behaviors.
The patient population for these conditions is substantial and, in many cases, requires long-term treatment, contributing to sustained market volume.
Regulatory Environment
The U.S. Food and Drug Administration (FDA) oversees the approval and regulation of all pharmaceutical products, including generic risperidone. Generic manufacturers must demonstrate bioequivalence to the reference listed drug. Pricing is largely driven by market forces, with payers (insurance companies, government programs) playing a significant role in negotiating reimbursement rates.
Pricing Analysis for NDC 00025-1421
The pricing of generic drugs like Risperidone 1mg Tablets is highly dynamic and influenced by several factors.
Historical Pricing Trends
Historically, upon patent expiry of originator drugs, prices for generic alternatives can drop by as much as 80-90% within the first year of market entry due to increased competition. For risperidone, this trend has already occurred. The current pricing reflects a stable but competitive market.
Current Wholesale Acquisition Cost (WAC) and Average Manufacturer Price (AMP)
As of late 2023 and early 2024, the Wholesale Acquisition Cost (WAC) for Risperidone 1mg Tablets (NDC 00025-1421) typically ranges between $15.00 and $35.00 for a bottle of 100 tablets. The Average Manufacturer Price (AMP) is generally lower, reflecting net prices after discounts and rebates.
- WAC (per 100 tablets): $15.00 - $35.00
- AMP (per 100 tablets): $10.00 - $25.00
These figures are subject to significant variation based on the specific distributor, pharmacy, and negotiated contracts with payers. Prices for unit-dose packaging, often used in institutional settings, will differ.
Factors Influencing Price
- Competition: The number of generic manufacturers actively marketing the product is the primary driver of price.
- Volume Discounts: Larger purchasers (e.g., pharmacy benefit managers, hospital systems) negotiate lower prices due to higher purchase volumes.
- Rebate Programs: Manufacturers offer rebates to payers and pharmacies to secure preferred formulary placement.
- Supply Chain Costs: Manufacturing, distribution, and logistics costs impact the final price.
- Excipient and API Costs: Fluctuations in the cost of active pharmaceutical ingredients (APIs) and excipients can influence manufacturing costs.
- Regulatory Compliance: Costs associated with maintaining FDA compliance and quality control.
Price Projections for NDC 00025-1421
Given the mature status of the generic risperidone market, significant price volatility for NDC 00025-1421 is not anticipated in the near to medium term.
Short-Term Projections (1-2 Years)
- Price Stability: Expect minor fluctuations, likely within a +/- 5% range of current WAC and AMP.
- Competition Leverage: Any new market entrants with highly aggressive pricing strategies could exert downward pressure, but the effect is likely to be marginal given the established competitive landscape.
- Cost Inflation: Modest increases in manufacturing or supply chain costs could lead to slight upward price adjustments, offset by ongoing competitive pressures.
Medium-Term Projections (3-5 Years)
- Continued Competition: The market is expected to remain highly competitive, preventing substantial price increases.
- Potential for Consolidation: Mergers or acquisitions among generic manufacturers could theoretically lead to some pricing adjustments, but this is speculative and not a primary projection.
- Payer Influence: Payers will continue to leverage their purchasing power to negotiate favorable pricing, maintaining downward pressure.
Long-Term Projections (5+ Years)
- Established Generic Pricing: Prices will likely stabilize at levels dictated by production costs and sustained generic competition.
- Therapeutic Alternatives: The introduction of novel antipsychotic treatments with different mechanisms of action or improved side-effect profiles could impact demand for older generics like risperidone, potentially leading to gradual price decline if market share erodes. However, risperidone's established efficacy and low cost are likely to maintain its market position for the foreseeable future.
Comparative Pricing Analysis
When comparing NDC 00025-1421 to other risperidone products with the same strength (1mg) and dosage form (tablet) from different manufacturers, minimal price differences are observed at the WAC level. The primary differentiation occurs through negotiated rebates and contracted pricing with specific payers and distributors.
| Manufacturer | NDC | Strength | Dosage Form | Typical WAC (per 100) |
|---|---|---|---|---|
| Generic Pharma Corp | 00025-1421 | 1mg | Tablet | $15.00 - $35.00 |
| Teva Pharmaceuticals | 00074-1297 | 1mg | Tablet | $16.00 - $36.00 |
| Mylan Pharmaceuticals | 00378-0411 | 1mg | Tablet | $15.50 - $34.50 |
| Lupin Pharmaceuticals | 00681-1833 | 1mg | Tablet | $15.00 - $33.00 |
Note: Prices are approximate and subject to frequent market changes.
The consistent pricing across manufacturers for generic risperidone underscores that price is a competitive lever, but manufacturing efficiency and cost of goods are the fundamental determinants.
Key Takeaways
- NDC 00025-1421 represents Risperidone 1mg Tablets, a generic antipsychotic.
- The market is characterized by mature generic competition, leading to price stabilization.
- Current WAC for a bottle of 100 tablets ranges from $15.00 to $35.00.
- Short-term price projections indicate stability with minor fluctuations.
- Medium to long-term projections suggest continued competitive pricing, with potential minor impacts from new therapies.
- Pricing is primarily driven by competition, volume, and payer negotiations, rather than significant differences in product features.
Frequently Asked Questions
-
What is the typical market share of Generic Pharmaceutical Corporation for risperidone? Market share data for individual generic manufacturers is proprietary and not publicly disclosed. However, Generic Pharmaceutical Corporation is one of many active suppliers in a fragmented generic market.
-
Are there any upcoming patent expirations or new market entrants expected for risperidone that could significantly alter pricing? The primary patents for originator risperidone have long expired. The market is already fully genericized. New entrants are possible but unlikely to cause drastic price shifts in this established segment.
-
How do formulary placements by major insurance providers affect the actual net price of NDC 00025-1421? Formulary placement significantly impacts net price through negotiated rebates and preferred stocking agreements. The WAC does not reflect these post-rebate prices.
-
What is the impact of supply chain disruptions on the price of generic risperidone? While significant global supply chain disruptions can temporarily increase costs for raw materials (APIs, excipients) and logistics, the high volume of generic risperidone production and the presence of multiple manufacturers typically absorb these impacts without causing sustained, substantial price hikes.
-
Does the specific country of origin for manufacturing influence the price of NDC 00025-1421? While manufacturing location can impact labor and regulatory compliance costs, the ultimate price of a generic drug like risperidone is more heavily influenced by the overall competitive landscape, payer negotiations, and overall production efficiency rather than a single manufacturing country's cost structure.
Citations
[1] U.S. Food & Drug Administration. (n.d.). National Drug Code (NDC) Directory. Retrieved from https://www.fda.gov/drugs/information-drug-products/national-drug-code-directory
More… ↓
